Ambroxol Hydrochloride/Salbutamol sulfate

盐酸氨溴索/硫酸沙丁胺醇

Report date: 2026/05/09 20:00:18

Base Information

Drug NameAmbroxol Hydrochloride/Salbutamol sulfate
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsSodium channel alpha subunitBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchial SpasmAsthma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Ambroxol HydrochlorideSalbutamol sulfate
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShandong Bestcomm Pharmaceutical Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShaanxi Synthetic Pharmaceutical Co LtdShandong Bestcomm Pharmaceutical Company Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchial SpasmAsthma +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A